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Abstract Generally emulsions are water-in-oil or oil-in-
water type, but emulsions may contain polar liquid as one
of the phase. Non-aqueous emulsions are useful in many
situations where presence of water is not desirable, and
formulation of active ingredients which undergo hydrolysis
or oxidation in the presence of water. The study was to
design a stable non-aqueous nanoemulsion (NANE) using
cosmetically approved ingredients as a vehicle for the
water-sensitive active ingredients. Non-aqueous nano-
emulsion was designed to increase the dermal penetration
and permeation and study solubility and dermal bioavail-
ability of griseofulvin. For better compliance, the NANEs
will be incorporated in cosmetics or personal care products.
A non-aqueous system was obtained with glycerin and
olive oil stabilized by glycerol monosterate with co-sur-
factant. It was observed that emulsification behavior is
completely unpredictable and conventional theories of
emulsification and HLB system cannot be applied here. An
optimized NANE was obtained through implementation of
pseudo-ternary phase diagram. Pseudo-ternary phase dia-
gram was constructed using surfactant and co-surfactant
ratio (1:1, 2:1, 3:1, 4:1) and nanoemulsion region was
determined and further characterized for pH, rheology,
globule size analysis, zeta potential and stability. Stability
studies (agitation, centrifugation, freeze thaw cycle,
accelerated stability) were carried out at 5, 25 and 40 C.
Cream was stable at 5 and 25. Results proved that NANE
can be used as vehicle for the poorly water-soluble drug,
suspension vehicles and oleogels.
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Introduction
The microemulsions can be used to deliver drugs via sev-
eral routes and their composition and structure enable them
to incorporate greater amount of drug than other drug
delivery systems [1]. Microemulsions are comparatively
thermodynamically stable systems and gained the wide
acceptance because of their enhanced drug solubilization,
thermodynamic stability, and ease of manufacture [2]. The
non-aqueous nanoemulsion (NANE) useful for drug
delivery and principally overcomes the problem of slow
and incomplete dissolution of poorly water-soluble drugs
with water unstable and/or unsavory drug [3–6].
Emulsion is one of the most convenient and advantageous
formulations in which one of the liquid phases is water;
however, emulsion can be formulated without an aqueous
phase to produce anhydrous, non-aqueous or oil-in-oil
emulsions/microemulsion [6]. Such systems can replace
conventional emulsions where the presence of water has to
be avoided [7–12]. Such systems can reduce the inherent
limitations and facilitate the formation of solubilized phases
from which absorption may occur. Unfortunately, the major
difficulty in formulating NANE arises from the lack of
appropriate data on surfactant action in relevant non-aque-
ous media, or indeed, the dearth of suitable surfactant
designed for such specialized system [13].
Oil-in-polyhydroxylic solvent microemulsion of poorly
water-soluble antifungal drug was designed and developed
using olive oil, glycerin and glycerol monosterate to
improve the stability and elegancy of NANE formulation
[14].
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The use of pseudo-ternary phase diagram is required to
map the optimal composition range for excipients; this
technique is mainly used to map the microemulsion areas
[15, 16]. Pseudo-ternary phase diagrams can be used to
show the influence of changes in the volume fractions of
the different phases on the phase behavior of the system
[17].
On the other hand, from the pharmacological point of
view, surfactants with low critical micelle concentration
(CMC) value have more stable micelles [18].
Surfactants with a high CMC value may dissociate into
monomers, their content may precipitate in the blood [19],
and they are not suitable for drug delivery. Often the use of
co-surfactants is required for the optimal formation of a
nano and microemulsion and co-surfactant is often the
second surfactant but may also refer to a low-molecular
weight amphiphile, such as an alcohol [19]. Co-surfactants
increase the flexibility of the surfactant film around the
nanoemulsion droplet. The role of the co-surfactant is to
overcome the repulsive forces of similar phases and fluidity
of the oil and water to increase the permeability of two
phases to form a microemulsion [20]. Short- and medium-
chain alcohols, such as butanol, pentanol, ethanol, isopro-
panol, or propylene glycol, are commonly added as co-
surfactants.
Nanoemulsions are characterized using dynamic light
scattering, polarized light microscopy, electrical conduc-
tivity, and rheology [21]. Dynamic light scattering is used
to measure nanoscale particles of liquid mediums such as
nanoemulsions.
In the present work, the formulation of NANE using
olive oil and glycerin is discussed and use of pseudo-ter-
nary phase diagram explored to map the optimal compo-
sition range for three excipients and can be used to show
the influence of changes in the volume fractions of the
different phases on the phase behavior of the system [21].
The precise coexistence/pseudo-ternary curve measure-
ment of a ternary nanoemulsion, consisting of olive oil,
GMS, and glycerin, at the critical volume fraction and a
constant molar ratio was determined.
Methods
Materials
Analytical grade materials were used for this study. Gris-
eofulvin, Glycerin (Loba Chemical, Mumbai, India), Olive
oil (Poona Chemical Laboratory, Pune, India), and Glyc-
erol monostearate (Research Lab Fine Chemical Industry,
Mumbai, India) were purchased. Methanol, chloroform,
distilled water, phosphate buffer pH (7.4) were also used
throughout the study. All other chemicals and reagent were
of analytical grade and were used without further
purification.
Construction of pseudo-ternary phase diagram
To investigate concentration range of components for the
existing boundary of NANE, pseudo-ternary phase diagram
was constructed using the titration method.
Titration method
The phase diagram was prepared with the 1:1, 2:1, 3:1,
4:1 weight ratio of Glycerol monostearate/Ethanol as
surfactant–co-surfactant mixture. The oil phase and the
surfactant mixture (w/w) were mixed with ratio of 1:9,
2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1. In the resultant
mixtures, glycerine was added dropwise till the first sign
of turbidity appeared and then clear solution after equi-
librium was observed to identify the end point. After
equilibrium was reached, the mixtures were checked
visually for phase clarity and flowability. The resultant
emulsion with a clear or bluish appearance, exhibiting
good stability (being stable after centrifugation for 10 min
at 2000 rpm) and flow ability was defined as a nano-
emulsion [22]. Ternary phase diagrams were constructed
using Chemix School 9.0 Software. The compositions are
expressed in Table 1.
Formulation of nonaqueous nanoemulsion (NANE)
A wide range of oils and surfactants (Table 1) were
screened for the formulation of NANE. The NANE con-
tains lower amount of surfactant having better stability, so
the optimized formula of NANE loaded with Griseofulvin
0.5 % (w/w) in 70 % of olive oil, required quantity of
different Smix (GMS and ethanol) ratio was added to oil
phase and mixture was make up to 100 % (w/w) with slow
addition of glycerin with continuous stirring using Ultra-
turrex homogenizer (Unique Biological, India)
(5000–6000 rpm) [23, 24] with gentle heating. All the
samples were stirred for 24 h at 5000 rpm using Ultratur-
rex homogenizer. After phase preparation, nanoemulsion
area was identified by visual inspection (a nanoemulsion is
optically clear and transparent) and polarized light
microscopy (Labomed, India). In each system, samples of
the NANE area were separated, and the o/g area of the
pseudo-ternary phase diagram was plotted using Chemix
School (3) software [25].
Globule size analysis
Globule size analysis of NANE was carried out through
Beckman coulter counter (Malvern size Analyzer,
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Germany) based on the laser diffraction phenomenon.
During a laser diffraction experiment, particles are illu-
minated in a collimated laser beam, causing the light to be
scattered in a variety of directions. Larger globules brought
a high intensity of scattering at low angles to the beam and
smaller particles, and create a low-intensity signal at far
wider angles. This angular scattering was measured with
specially designed detectors and particle size distribution is
resolute [26–28]. The polydispersity index (PI) of NANE
gives an indication of width of the size distribution of
particle population in the nanoemulsion.
Stability study
The chemical and physical stability of the NANE was
subjected to stability study (Remi Corp., Mumbai). The
thermodynamic stability of NANE was resolute with cen-
trifugation at 3500 rpm and 25 ± 1 C for 30 min. Non-
aqueous nanoemulsion was examined for changes in color,
viscosity and drug content for the period of 3 months [29–
32].
Agitation test
Accurately weighed 5 gm of NANE was placed in recip-
rocating shaker (Remi Corp., Mumbai) at 60 cycles/min for
24 h at room temperature. After stipulated period cream
was observed for any signs of phase separation [29].
Centrifugation test
Accurately weighed 5 g of NANE was centrifuged (Remi
Corp, Mumabi) at 3500 rpm for 30 min. After stipulated
period, cream was observed for any signs of phase sepa-
ration [30].
Freeze–thaw cycles
The NANE was kept at -10 and 25 C for 48 h and
observed for phase separation and viscosity (Brookfield
Rheometer R/S, Germany) after three freeze–thaw cycles’
separation [31].
Drug content
The Griseofulvin NANE was evaluated for its drug content
using methanol as blank at 291 nm [31, 32]. 0.25 g of
NANE was dissolved in 50 mL of methanol, and sonicated
for 30 min. The sample was extracted with methanol and
analyzed at 291 nm using UV–Visible Spectrophotometer
(Shimedazu Corp., Japan).
Table 1 Effect of type of surfactant and their combinations on emulsification of o/g and g/o non aqueous nanoemulsion (NANE)
Type of surfactant Appearance of non aqueous nanoemulsion Stability of NANE Type of NANE
Tween 20 M ? –
Tween 40 M ? –
Tween 60 M ? –
Tween 80 M ? –
Span 20 O ?? o/g
Span 40 O ?? o/g
Span 60 O ?? o/g
Span 80 O ??? o/g
Span 85 M ??? o/g
SLS C - –
GMS C ??? g/o
Tween 80 ? Span 80 M ? o/g
Tween 80 ? Span 40 O -
Tween 60 ? Span 80 O -
Tween 60 ? Span 40 O -
Tween 60 ? Span 20 – #
Tween 80 ? Span 20 – #
Tween 20 ? Span 20 – #
Emulsification/stable: no phase separation for at least 7 days
# NO emulsification, – phase separation, ? phase separation within 1 week, ?? stable up to 3 weeks, ??? stable, C cream like consistency,
O opaque, M milky, o/g mineral oil-in-glycerin type of non aqueous nanoemulsion (NANE), g/o glycerin-in-mineral oil type of non aqueous
nanoemulsion (NANE)




Conventional emulsion shows better stability when having
the optimum HLB with hydrophilic and lipophilic groups
[4]. Initially, a combination of surfactants was screened
using hydrophilic and hydrophobic surfactants in 1:1 ratio.
But, it was observed that single surfactant shows more
stability in formulation of NANE than the combination of
surfactants (Table 1). All surfactants produce stable
nanoemulsion, viz. Tween 20, 40, 60 and 80 and able to
formulate a NANE having milky appearance at 10 %
surfactant concentration but phase separation occurred
within a week. Hydrophobic surfactants were found to be
more efficient; Span 20 and 40 produced emulsions which
were stable up to 3 weeks. Span 80 and 85 produced
NANE at even lower surfactant concentrations which were
stable for a period more than 4 weeks. So these formula-
tions were considered as stable for formulating NANE of
griseofulvin.
Critical micelle concentration
Critical micelle concentration is not a point concentration,
but a range below CMC surface active agent is preferen-
tially adsorbed mainly at air–water interface as monomer
[5]. When surfactant monomer encounters the polyhydr-
oxylic environment, polyhydroxylic molecule rejects the
water-insoluble hydrocarbon tail of amphiphiles. The tail
directs away from the polar solvent, while the hydrophilic
head is attached by polar solvent molecule by electrostatic
attraction force. As the concentration increases in the
interface, the bulk phase becomes saturated with monomer.
As the concentration of surfactant in solution increases, the
surface tension decreases. The CMC was measured and
2 9 10-4 was found satisfactory.
Pseudo-ternary phase diagram
The chemix school (3) pseudo-ternary phase diagram was
used for the selection of optimized batch on basis of
emulsification region. The phases were identified by visual
inspection. A nanoemulsion is optically clear and trans-
parent and the samples with transparent appearance were
separated for further investigations.
Pseudo-ternary phase diagrams were constructed using
olive oil, GMS (surfactant) and ethanol (co-surfactant)
mass ratio (Figs. 1, 2, 3, 4). It was observed that the sur-
factant alone was ineffective in reducing the g/o interfacial
tension enough to provide a NANE with desirable
properties.
Effect of surfactant and co-surfactant ratio on NANE
A large NANE was obtained through the surfactant-rich
apex, maximum concentration of oil that could be solubi-
lized and increased amount of co-surfactant with respect to
surfactant. In Smix 1:1 ratio maximum amount of oil that
could be solubilized was 15 % (w/w). This might be due to
the incorporation of co-surfactant and resembles for
enhanced penetration of the oil phase in the hydrophobic
zone of the surfactant monomer, which in turn reduced the
interfacial tension and increased the flexibility and fluidity
of the interface, ultimately leading to increased entropy of
the system.
When co-surfactant ratio reaches up to 2:1, the total area
of NANE decreased. Therefore, as the surfactant ratio
increased, and nanoemulsion area decreased. In contrast
Fig. 1 Pseudo-ternary phase diagram of the griseofulvin non-aque-
ous nanoemulsion (NANE) region with combination of co-surfactant
(ethanol) and surfactant (GMS), i.e., Smix; (a) Smix ratio 1:1
Fig. 2 Pseudo-ternary phase diagram of the griseofulvin non-aque-
ous nanoemulsion (NANE) region with combination of co-surfactant
(ethanol) and surfactant (GMS), i.e., Smix; (b) Smix ratio 2:1
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when surfactant concentration of Smix was increased from
1:1, 2:1, 3:1, 4:1, depletion in nanoemulsion region was
observed. It might be because of insufficient co-surfactant
concentration, resembling for reduction in an interfacial
tension and provides the flexibility to the interface and
nanoemulsion region. The literature [5] also supports that
the Smix 1:1 possesses the maximum NANE area as
compared to the other ratio indicating that surfactant and
co-surfactant mass ratio has effect on phase ratio (Fig. 5).
Globule size analysis
A key distinctive property of nanoemulsion is its nanoscale
particle size. The size distribution analysis of selected
NANE was performed using Malvern nanosizer. A graph-
ical representation of particle size distribution of freshly
prepared griseofulvin loaded NANE (Fig. 6) shows a
broader globule size distribution and globule size intensity
ranges from 5.59 to 33.63 nm. The droplet size resembles
for rate and extent of drug release, absorption and stability
of NANE.
As the distance from the surface of nanoemulsion
increases, the potential gradually decreases. The zeta
potential can be related to the stability of colloidal dis-
persions for molecules and particles that are small
enough; a high zeta potential will confer stability, i.e., the
solution or dispersion will resist aggregation. When the
potential is low, attraction exceeds the repulsion and
dispersion will break out to flocculate. So, colloids with
high zeta potential (negative or positive) are electrically
stabilized while colloids with low zeta potentials tend to
coagulate or flocculate. So the nanoemulsion shows the
zeta potential -0.787 having low potential but having
good stability.
Stability studies
Non-aqueous nanoemulsion droplets exhibit Brownian
movement and no coalescence of droplets takes place
unless droplets impinge upon each other owing to their
Brownian movement. Agitation can contribute to the
energy with which two droplets impinge upon each other.
After agitation on a reciprocating shaker for 24 h, there
was no phase separation in NANE indicating that it has
good stability and can withstand the mechanical forces
during the transportation and handling.
Centrifugation was carried out to examine the effect of
gravity on the NANE. NANE showed no phase separation
after centrifugation for 30 min at 3500 rpm indicating that
cream has a good stability over the gravitational forces.
Fig. 3 Pseudo-ternary phase diagram of the griseofulvin non-aque-
ous nanoemulsion (NANE) region with combination of co-surfactant
(ethanol) and surfactant (GMS), i.e., Smix; (c) Smix ratio 3:1
Fig. 4 Pseudo-ternary phase diagram of the griseofulvin non-aque-
ous nanoemulsion (NANE) region with combination of co-surfactant
(ethanol) and surfactant (GMS), i.e., Smix; (d) Smix ratio 4:1
Fig. 5 Pseudo-ternary phase diagram of optimized griseofulvin non-
aqueous nanoemulsion (NANE) region with co-surfactant (ethanol)
and surfactant (GMS)
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Freeze–thaw cycle is a stability test in which emulsions
are subjected to two extreme temperature conditions. For
the freeze–thaw cycling, samples were placed alternately at
-10 and 25 C for 48 h at each temperature. There was no
phase separation after three freeze–thaw cycles indicating a
good thermal stability of the formulation. Also there were
no significant changes in viscosity measured before and
after performing the test.
Non-aqueous nanoemulsion was monitored for changes
in color, viscosity and drug content for the period of
3 months. During studies, formulation was kept at low-
temperature (5 C), moderate-temperature (25 C) and
high-temperature (40 C) conditions.
It was observed that formulation was not sensitive to the
low temperature. Drug content of the NANE was found to be
decreased from 98.13 ± 0.56 to 97.50 ± 0.35 % within
3 months at 5 C with no significant change in the chemical
composition of the formulation. But there were some extent
of changes in the viscosity of the formulation. Initial viscosity
of the formulation was found to be 11043cPs up to 1 month;
thereafter decrease in the viscosity was 10351 cPs. Initial
increase in viscosity might be due to the gelation, because
GMS at higher concentration causes the gelation. Color of the
formulation did not change at the low temperature. So it was
observed that NANE was stable at low temperature.
Stability study at 25 C observed for color, drug content
and viscosity. There was decrease in the drug content at
25 C from 98.75 ± 0.13 to 97.50 ± 0.13 % within
3 months. As seen in the case of low temperature, there
was an initial increase in viscosity of 11043 cPs followed
by a decrease up to 9396 cPs (Fig. 7). Greater decrease in
the viscosity was observed due to increase in the temper-
ature. Also there was change in the color of the formula-
tion; color was changed from fresh white to dull white.
At 40 C, a distinct phase separation occurs within 48 h
because of rise in temperature resembling for decrease in
viscosity of formulation, leads to formation of larger
globule sizes; therefore, stability study at higher tempera-
ture was terminated. From the stability studies, it was
evident that NANE is stable at moderate and low temper-
atures. The globule size of NANE and aqueous formulation
was found to be significant throughout the stability study.
Conclusion
During formulation, it was found that emulsification was
achieved when single surfactant was used, rather than
surfactant combination, and hydrophobic surfactants was
found to be more efficient than hydrophilic surfactants.
Stable NANE can be obtained using glycerin as dispersed
phase, olive oil as continuous phase and glycerol monos-
tearate as surfactant. This emulsion has improved the sta-
bility of griseofulvin.
Fig. 6 Effect of % cumulative
intensity (D10, D20, D30 and
D40) on globule size
distribution of optimized non-
aqueous nanoemulsion (NANE)
of griseofulvin
Fig. 7 Effect of changes in viscosity on conventional and non-
aqueous nanoemulsion (NANE) of griseofulvin during stability study
at 5, 25 and 45 C at 3 months period
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